In Treatment of Neuropathic pain Citgaba-MN Tablet is a combination of medicines used to treat long-lasting (chronic) pain caused by nerve damage due to diabetes, shingles, or spinal cord injury. It reduces pain and its associated symptoms such as mood changes, sleep problems, and tiredness. It is thought to work by interfering with pain signals that travel through the damaged nerves and the brain. It also contains nutritional supplements that are essential for improving nerve conduction. Taking Citgaba-MN Tablet regularly will improve your physical and social functioning and overall quality of life. It takes a few weeks to work so you need to take it regularly even if you feel it is not doing any good. Once your symptoms have gone you should still keep taking the medicine until your doctor advises you to stop.
Citgaba
Pregnancy : CONSULT YOUR DOCTOR
MN Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Citgaba
Driving : UNSAFE
MN Tablet may cause side effects which could affect your ability to drive. As Citgaba
Kidney : CAUTION
MN Tablet should be used with caution in patients with kidney disease. Dose adjustment of Citgaba
Liver : SAFE IF PRESCRIBED
MN Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Citgaba
If you miss a dose of Citgaba-MN Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Vyomax Lifesciences Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Addii Biotech Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Everwell Pharma Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Lamiaceae Healthcare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Stallion Laboratories Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Varima Pharma Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Minitoss Medicines || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Zenacts Pharma || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Novalab Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)